[4.2.0]

TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT 2A receptor pharmacological tool, or none of the above?

Giuseppe Di Giovanni, Philippe De Deurwaerdère
Neuropharmacology. 2018-11-01; 142: 20-29
DOI: 10.1016/j.neuropharm.2017.10.004

PubMed
Lire sur PubMed



 

Auteurs Bordeaux Neurocampus